Cutler Group LP Axogen, Inc. Transaction History

Cutler Group LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$7.26 - $10.7 $8,712 - $12,840	-1,200 Closed	0 $0
Q4 2021 Jan 18, 2022	BUY	$8.8 - $16.0 $7,920 - $14,400	900 Added 300.0%	1,200 $11,000
Q3 2019 Oct 28, 2019	SELL	$12.09 - $20.46 $2,418 - $4,092	-200 Reduced 40.0%	300 $3,000
Q2 2019 Aug 09, 2019	SELL	$18.5 - $25.47 $31,450 - $43,299	-1,700 Reduced 77.27%	500 $9,000
Q1 2019 May 10, 2019	BUY	$14.62 - $22.13 $17,544 - $26,556	1,200 Added 120.0%	2,200 $46,000
Q4 2018 Feb 05, 2019	SELL	$17.09 - $38.25 $5,127 - $11,475	-300 Reduced 23.08%	1,000 $20,000
Q3 2018 Nov 07, 2018	SELL	$34.05 - $55.9 $34,050 - $55,900	-1,000 Reduced 43.48%	1,300 $47,000
Q2 2018 Aug 10, 2018	BUY	$36.15 - $52.5 $75,915 - $110,250	2,100 Added 1050.0%	2,300 $115,000
Q1 2018 May 11, 2018	BUY	$24.4 - $40.25 $4,880 - $8,050	200 New	200 $7,000

179

36.2M

82.6K

1.1K

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $738M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.